There aren't quite as many longs on the list as I expected because of all the bullish candlesticks yesterday, but the list is more than long enough. A good percentage of the hammers made yesterday were on stocks that are in intermediate and/or long term downtrends, so I had to pass on those.
Currently holding:
Long - URBN
Short - none
Looking for swing trade entries in:
Longs - ARTC, CRL, EBAY, ESMC - getting crush in the pre-market, HHH, INFY, ISRG, JOSB, MSO, TEK, WBSN
Shorts - UTSI
Potential day trades:
(From Briefing.com)
Gapping DownMSPD -13.5% (guides lower; Needham downgrade), ESMC -9.1% (reports JunQ results), NABI -8.1% (profit taking after 15% move yesterday), CORV -8.1% (changes name to Broadwing), TSCO -7.2% (guides Q3 EPS lower), VISG -5.3% (lost State Dept contract to IDNX - see Gapping Up), ASML -4.1% (possible push-outs, lower margins), NFLX -3.9% (started with a Sell at Wedbush; tgt $13), SLAB -3.7% (Agere guidance), KFX -3.6% (WSJ article), PIXR -2.4% (Disney's Iger says Pixar deal unlikely), TZOO -2% (CD/ORBZ deal seen as competitive threat).
Gapping Up
coming...ORBZ +30% (Cendant to acquire Orbitz), GENR +15% (gets $100k grant for obesity program), IDNX +16% (wins US State Dept facial recognition contract), NTGR +10% (launches Prosafe Network Management System), YAKC +9% (newsletter mention), SIRI +9% (says radios will be in Wal-Mart nationwide; Bear Stearns upgrade), PCLN +10% (in sympathy with ORBZ), BLUD +7.8% (beats by a penny, guides Y05 EPS above consensus), EGHT +7.3% (signs retail pact with DataVision), NXTP +6.6% (raises adjusted EBITDA guidance), ROCK +5.9% (guides Q3 higher), SLR +5% (reports AugQ), IACI +2.6% (see ORBZ), GDT +2.1% (target raised to $74 from $63 at Deutsche).... Under $3: BIOM +39% (FDA grants fast track status), ARDM +21% (co and Novo expand licensing rights), SATC +15% (receives $1.8 mln order).
